Daniel S.W. Tan
Impact in
- Oncology top 1%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 86
- Lung Cancer Diagnosis and Treatment 22
- Gastric Cancer Management and Outcomes 6
- Oncology 74
- Cancer Immunotherapy and Biomarkers 25
- Lung Cancer Research Studies 20
- Colorectal Cancer Treatments and Studies 13
- Co-authors
- Aaron C. Tan (12 shared papers)Alexander Drilon (15 shared papers)Gillianne Lai (8 shared papers)Zishuo I. Hu (1 shared paper)Tony Mok (12 shared papers)Angela Takano (11 shared papers)Timothy R. Rebbeck (1 shared paper)Wan‐Teck Lim (19 shared papers)
- Journals
- Annals of Oncology (22 papers)Journal of Thoracic Oncology (21 papers)Journal of Clinical Oncology (11 papers)Cancer Research (5 papers)Lung Cancer (5 papers)
- Partner nations
- SingaporeUnited StatesSouth Korea
In The Last Decade
Daniel S.W. Tan
153 papers receiving 4.3k citations
Daniel S.W. Tan's Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 1.6k
- Cancer Research 752
- Hepatology 206
- Pathology and Forensic Medicine 289
Countries citing papers authored by Daniel S.W. Tan
This map shows the geographic impact of Daniel S.W. Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S.W. Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S.W. Tan more than expected).
Fields of papers citing papers by Daniel S.W. Tan
This network shows the impact of papers produced by Daniel S.W. Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S.W. Tan. The network helps show where Daniel S.W. Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel S.W. Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations Hit paper breakdown → | 2022 | 454 |
| 2 | 2017 | 286 | |
| 3 | Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor–Dysregulated Non–Small-Cell Lung Cancer Hit paper breakdown → | 2018 | 251 |
| 4 | Non-small-cell lung cancer Hit paper breakdown → | 2024 | 193 |
| 5 | 2016 | 142 | |
| 6 | 2021 | 141 | |
| 7 | 2015 | 139 | |
| 8 | 2009 | 136 | |
| 9 | Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial Hit paper breakdown → | 2022 | 129 |
| 10 | 2007 | 125 | |
| 11 | 2016 | 112 | |
| 12 | 2005 | 87 | |
| 13 | 2011 | 79 | |
| 14 | 2022 | 75 | |
| 15 | 2023 | 72 | |
| 16 | 2023 | 70 | |
| 17 | 2010 | 66 | |
| 18 | 2009 | 62 | |
| 19 | The changing treatment landscape of EGFR-mutant non-small-cell lung cancer Hit paper breakdown → | 2024 | 59 |
| 20 | 2010 | 57 |
About Daniel S.W. Tan
Daniel S.W. Tan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Surgery, having authored 161 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (86 papers), Cancer Immunotherapy and Biomarkers (25 papers), Cancer Genomics and Diagnostics (23 papers), Lung Cancer Diagnosis and Treatment (22 papers), Lung Cancer Research Studies (20 papers), Colorectal Cancer Treatments and Studies (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.6k citations), Cancer Research (752 citations), Hepatology (206 citations) and Pathology and Forensic Medicine (289 citations). Daniel S.W. Tan has collaborated with scholars based in Singapore, United States and South Korea. Frequent co-authors include Aaron C. Tan, Alexander Drilon, Gillianne Lai, Zishuo I. Hu, Tony Mok, Angela Takano, Timothy R. Rebbeck, Wan‐Teck Lim, N. Gopalakrishna Iyer and Kevin Lee Min Chua. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Journal of Clinical Oncology, Cancer Research and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.